PMID- 38325289 OWN - NLM STAT- MEDLINE DCOM- 20240226 LR - 20240409 IS - 1945-7170 (Electronic) IS - 0013-7227 (Print) IS - 0013-7227 (Linking) VI - 165 IP - 4 DP - 2024 Feb 20 TI - mTOR Regulates Mineralocorticoid Receptor Transcriptional Activity by ULK1-Dependent and -Independent Mechanisms. LID - 10.1210/endocr/bqae015 [doi] LID - bqae015 AB - The mineralocorticoid receptor (MR) is a transcription factor for genes mediating diverse, cell-specific functions, including trophic effects as well as promoting fluid/electrolyte homeostasis. It was reported that in intercalated cells, phosphorylation of the MR at serine 843 (S843) by Unc-51-like kinase (ULK1) inhibits MR activation and that phosphorylation of ULK1 by mechanistic target of rapamycin (mTOR) inactivates ULK1, and thereby prevents MR inactivation. We extended these findings with studies in M1 mouse cortical collecting duct cells stably expressing the rat MR and a reporter gene. Pharmacological inhibition of ULK1 dose-dependently increased ligand-induced MR transactivation, while ULK1 activation had no effect. Pharmacological inhibition of mTOR and CRISPR/gRNA gene knockdown of rapamycin-sensitive adapter protein of mTOR (Raptor) or rapamycin-insensitive companion of mTOR (Rictor) decreased phosphorylated ULK1 and ligand-induced activation of the MR reporter gene, as well as transcription of endogenous MR-target genes. As predicted, ULK1 inhibition had no effect on aldosterone-mediated transcription in M1 cells with the mutated MR-S843A (alanine cannot be phosphorylated). In contrast, mTOR inhibition dose-dependently decreased transcription in the MR-S843A cells, though not as completely as in cells with the wild-type MR-S843. mTOR, Raptor, and Rictor coprecipitated with the MR and addition of aldosterone increased their phosphorylated, active state. These results suggest that mTOR significantly regulates MR activity in at least 2 ways: by suppressing MR inactivation by ULK1, and by a yet ill-defined mechanism that involves direct association with MR. They also provide new insights into the diverse functions of ULK1 and mTOR, 2 key enzymes that monitor the cell's energy status. CI - Published by Oxford University Press on behalf of the Endocrine Society 2024. FAU - Ali, Yusuf AU - Ali Y AUID- ORCID: 0000-0003-0753-3590 AD - Research Service, G. V. (Sonny) Montgomery VA Medical Center, Jackson, MS 39216, USA. AD - Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA. FAU - Gomez-Sanchez, Celso E AU - Gomez-Sanchez CE AUID- ORCID: 0000-0002-9882-2082 AD - Research Service, G. V. (Sonny) Montgomery VA Medical Center, Jackson, MS 39216, USA. AD - Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA. FAU - Plonczynski, Maria AU - Plonczynski M AD - Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA. FAU - Naray-Fejes-Toth, Aniko AU - Naray-Fejes-Toth A AD - Department of Physiology, Dartmouth Medical School, Lebanon, NH 03755, USA. FAU - Fejes-Toth, Geza AU - Fejes-Toth G AD - Department of Physiology, Dartmouth Medical School, Lebanon, NH 03755, USA. FAU - Gomez-Sanchez, Elise P AU - Gomez-Sanchez EP AUID- ORCID: 0000-0002-4432-4950 AD - Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA. LA - eng GR - I01 BX004681/BX/BLRD VA/United States GR - R01 HL144847/HL/NHLBI NIH HHS/United States GR - U54 GM115428/GM/NIGMS NIH HHS/United States PT - Journal Article PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 4964P6T9RB (Aldosterone) RN - EC 2.7.11.1 (Autophagy-Related Protein-1 Homolog) RN - 0 (Ligands) RN - EC 2.7.11.1 (Mechanistic Target of Rapamycin Complex 1) RN - EC 2.7.1.1 (mTOR protein, rat) RN - 0 (Multiprotein Complexes) RN - 0 (Rapamycin-Insensitive Companion of mTOR Protein) RN - 0 (Receptors, Mineralocorticoid) RN - 0 (Regulatory-Associated Protein of mTOR) RN - 0 (RNA, Guide, CRISPR-Cas Systems) RN - W36ZG6FT64 (Sirolimus) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - 0 (Transcription Factors) RN - EC 2.7.11.1 (ULK1 protein, rat) RN - EC 2.7.11.1 (Ulk1 protein, mouse) RN - EC 2.7.1.1 (mTOR protein, mouse) SB - IM MH - Animals MH - Mice MH - Rats MH - *Aldosterone MH - Autophagy-Related Protein-1 Homolog/genetics/metabolism MH - Ligands MH - Mechanistic Target of Rapamycin Complex 1/metabolism MH - Multiprotein Complexes/metabolism MH - Phosphorylation MH - Rapamycin-Insensitive Companion of mTOR Protein/metabolism MH - *Receptors, Mineralocorticoid/genetics/metabolism MH - Regulatory-Associated Protein of mTOR MH - RNA, Guide, CRISPR-Cas Systems MH - Sirolimus/pharmacology MH - TOR Serine-Threonine Kinases/metabolism MH - Transcription Factors/metabolism PMC - PMC10887451 OTO - NOTNLM OT - M1 cell OT - Raptor OT - Rictor OT - ULK1 OT - aldosterone OT - mTOR OT - mineralocorticoid receptor EDAT- 2024/02/08 00:41 MHDA- 2024/02/26 06:42 PMCR- 2024/02/07 CRDT- 2024/02/07 18:16 PHST- 2023/09/25 00:00 [received] PHST- 2024/02/26 06:42 [medline] PHST- 2024/02/08 00:41 [pubmed] PHST- 2024/02/07 18:16 [entrez] PHST- 2024/02/07 00:00 [pmc-release] AID - 7603218 [pii] AID - bqae015 [pii] AID - 10.1210/endocr/bqae015 [doi] PST - ppublish SO - Endocrinology. 2024 Feb 20;165(4):bqae015. doi: 10.1210/endocr/bqae015.